HEALTHY SAVINGS: MEDICAL TECHNOLOGY &

THE ECONOMIC BURDEN OF DISEASE

Study by Milken Institute. Authors: Anusuya Chatterjee, Jaque King, Sindhu Kubendran, and Ross DeVol. To view the full study, visit: http://lifechanginginnovation.org/get-facts

IMPACT OF DIABETES

25.8

AFFECTS=

million Americans

$245

COSTS=

billion

a year

HEALTH SYSTEM & ECONOMIC SAVINGS

Use of insulin pumps for treatment of people with diabetes generates net cost savings, providing better disease management.

$5,886

$34.9M

annual savings /person affected

increased tax revenue

ECONOMIC IMPACT OF INSULIN DEPENDENT DIABETES, 2005-2010*

Per Person Affected

Insulin pump

$ thousands
45

Insulin, no pump

AVERAGE ANNUAL ECONOMIC BURDEN

39.0

40

35.6

35
30

29.0

27.5

25

2008-2010 ($)

30.6

27.7

24.9

22.3

30.4

29.4
22.8

24.9

20
15
10

2005

2006

2007

2008

2009

Insulin pump

$24,217.5

Insulin, no pump

$30,103.2

Average savings

$5,885.8

2010

* Includes treatment expenditures and indirect impacts.

THE FUTURE
Increased incentives for medical technology
investment used to treat diabetes will generate
even larger net savings over time.

Reduced incentives for medical technology used to

treat diabetes will result in larger net costs.

$ billions
45

$ billions

$225.4

40

42.13

GAIN

20
15
10

26.97

-10.0

15.76

0.00

2010

-6.35

$101.1

-15.0

7.85

LOSS

-2.79

-5.0

30
25

0.00
-0.84

billion

35

0.0

-12.65

billion

-20.0

2.74
-23.52

-25.0

2015

2020

2025

2030

2035

2010

2015

2020

2025

*Screening of healthy population not included.

1. American Diabetes Association. Economic Cost of Diabetes in the US in 2012. [published online ahead of print March 6, 2013] Diabetes Care. DOI:10.2337/dc12-26255.

2030

2035